Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Loo Gan C, Huang J, Pan E, Xie W, Schmidt AL, Labaki C, Meza L, Bouchard G, Li H, Jackson-Spence F, Sánchez-Ruiz C, Powles T, Kumar SA, Weise N, Hall WA, Rose BS, Beuselinck B, Suarez C, Pal SK, Choueiri TK, Heng DYC, McKay RR. Loo Gan C, et al. Among authors: rose bs. Eur Urol Oncol. 2023 Apr;6(2):204-211. doi: 10.1016/j.euo.2022.10.004. Epub 2022 Nov 1. Eur Urol Oncol. 2023. PMID: 36328934
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial.
Mell LK, Pugh SL, Jones CU, Nelson TJ, Zakeri K, Rose BS, Zeitzer KL, Gore EM, Bahary JP, Souhami L, Michalski JM, Hartford AC, Mishra MV, Roach M 3rd, Parliament MB, Choi KN, Pisansky TM, Husain SM, Malone SC, Horwitz EM, Feng F. Mell LK, et al. Among authors: rose bs. Eur Urol. 2024 Apr;85(4):373-381. doi: 10.1016/j.eururo.2023.01.020. Epub 2023 Jan 28. Eur Urol. 2024. PMID: 36710205
Low-Value Prostate-Specific Antigen Screening in Older Males.
Kalavacherla S, Riviere P, Javier-DesLoges J, Banegas MP, McKay RR, Murphy JD, Rose BS. Kalavacherla S, et al. Among authors: rose bs. JAMA Netw Open. 2023 Apr 3;6(4):e237504. doi: 10.1001/jamanetworkopen.2023.7504. JAMA Netw Open. 2023. PMID: 37040113 Free PMC article.
Prognostic Value of the Intermediate-risk Feature in Men with Favorable Intermediate-risk Prostate Cancer: Implications for Active Surveillance.
Sherer MV, Leonard AJ, Nelson TJ, Courtney PT, Guram K, Rodrigues De Moraes G, Javier-Desloges J, Kane C, McKay RR, Rose BS, Bagrodia A. Sherer MV, et al. Among authors: rose bs. Eur Urol Open Sci. 2023 Feb 20;50:61-67. doi: 10.1016/j.euros.2023.02.002. eCollection 2023 Apr. Eur Urol Open Sci. 2023. PMID: 37101776 Free PMC article.
Treatment Landscape of Renal Cell Carcinoma.
Chen YW, Wang L, Panian J, Dhanji S, Derweesh I, Rose B, Bagrodia A, McKay RR. Chen YW, et al. Curr Treat Options Oncol. 2023 Dec;24(12):1889-1916. doi: 10.1007/s11864-023-01161-5. Epub 2023 Dec 28. Curr Treat Options Oncol. 2023. PMID: 38153686 Free PMC article. Review.
Comparison of outcomes for Hispanic and non-Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database.
Guram K, Huang J, Mouchati C, Abdallah N, Jani C, Navani V, Xie W, El Zarif T, Adib E, Gebrael G, Agarwal N, Li H, Labaki C, Labban M, Ruiz Morales JM, Choueiri TK, Chin Heng DY, Mittal A, Hansen AR, Rose BS, McKay RR. Guram K, et al. Among authors: rose bs. Cancer. 2024 Jun 1;130(11):2003-2013. doi: 10.1002/cncr.35216. Epub 2024 Jan 31. Cancer. 2024. PMID: 38297953
180 results